TAILIEUCHUNG - HISTORIC RESOURCES SURVEY HOLLYWOOD REDEVELOPMENT PROJECT AREA

The success of Selznick, in particular, as an independent producer working closely with the studios, pointed the way towards what was to be the future structure of Hollywood production, which became increasingly organized on a contracted-out basis from the 1950s onwards. The studio production-line system gave way to the package system, in which individual film projects were put together on a one- off basis. A great deal of Hollywood production today can be described as ‘independent’ in this sense, in that projects are often initiated and pursued by entities that exist formally beyond the bounds of the majors. These include production. | Historic resources survey Hollywood redevelopment Project Area Prepared for Community Redevelopment Agency Prepared by Chattel Architecture Planning Preservation Inc. 13417 Ventura Boulevard Sherman Oaks CA 91423 February 2010 Intensive Historic Resources Survey Hollywood Redevelopment Project Area Prepared for Community Redevelopment Agency of the City of Los Angeles Prepared by Chattel Architecture Planning Preservation Inc. February 2010 LIST OF CONTRIBUTORS Chattel Architecture Planning Preservation. Inc. Robert Chattel Principal Preservation Architect Jenna Snow Senior Associate Project Manager Shannon Ferguson Senior Associate Gabrielle Harlan Senior Associate Kathryn McGee Associate II Veronica Gallardo Junior Associate Justin Greving Associate I Morgan Chee Intern Allison Lyons Intern Tanya Sorrell Architectural Historian LSA Associates .

• Sân khấu điện ảnh
• Clinical Pattern
• Diagnostics and Therapy
• Severe Cutaneous
• Novel Polymorphisms
• Coronary Artery Disease
• Multifunctional Role
• Multidrugresistant MRSA
• Prevalence of MRSA in clinical samples
• MRSA in clinical samples
• Antibiotic sensitivity pattern
• Antibiotic susceptibility pattern
• Prevalence of MRSA
• Clinical isolates of staphylococcus aureus
• Tertiary care hospital
• Prevalence of MRSA among clinical isolates
• Antibiotic susceptibility
• Clinical isolates
• Neonatal septicemia
• Clinical isolates of neonatal septicemia
• Antimicrobial sensitivity pattern
• Methicillin resistant staphylococcus aureus
• Methicillin resistant coagulase negative
• Staphylococcus isolated
• Various clinical samples
• Various clinical specimens
• Klebsiella species isolated
• Medical college and hospital
• Obtained by Kirby Bauer
• Pseudomonas aeruginosa
• Piperacillin Tazobactum
• Klebsiella pneumoniae
• ESBL producing Klebsiella pneumoniae
• Antimicrobial susceptibility pattern
• ESBL producing clinical isolates
• Appropriate infection control measures
• Multidrug resistance
• Methicillin resistant staphylococcus aureus isolated
• Various clinical specimen
• Tertiary care post graduate teaching institute
• Pseudomonas aeruginosa (P aeruginosa)
• Antimicrobial resistance pattern
• Government medical college
• Antimycotic susceptibility
• Chromogenic agar
• Conventional method
• Antimycotic susceptibility pattern
• Candida species isolated
• Enterococcal species
• Vancomycin resistance
• Infection control
• Clinical isolates of enterococci
• Nosocomial infection
• Gram negative non fermenting bacteria
• Resistant pattern
• Rural population in South India
• Adverse cutaneous drug reaction
• Maculopapular rash
• Toxic epidermal necrolysis
• Cutaneous drug reaction
• Antimicrobial susceptibility
• Vancomycin resistant enterococci
• Bacterial infection
• Susceptibility pattern
• Multi drug resistant
• Acinetobacter species among clinical isolates
• Susceptibility pattern of Acinetobacter species
• Incidence of Acinetobacter species
• Hospital can minimize its incidence
• Antibiotic sensitivity
• Antibiotic resistance
• High level aminoglycoside resistance
• Isolation of enterococcus
• Microbiological study
• Wound samples
• Staphylococcus aureus isolated
• Escherichia coli
• Dynamism in resistance pattern
• Drift from Indian council of medical
• Antimicrobial use guidelines
• Clinical specimens
• ESBL producers
• Resistance pattern
• Extended spectrum beta lactamase producers
• Klebsiella spp
• Clavulanic acid
• In vitro antimicrobial susceptibility pattern
• ESBL producing Escherichia coli
• Blood stream
• Bacteriological investigation
• Escherichia coli isolated
• Non Fermenting gram negative bacilli
• Pseudomonas aeurginosa
• Polymyxin B
• BMC Veterinary Research
• Equine metabolic syndrome
• Hyperinsulinaemia associated laminitis
• Insulin dysregulation
• Clinical cases
• Proteus species
• Biofilm production